Haptoglobin glycoforms in a case of carbohydrate-deficient glycoprotein syndrome
- PMID: 10972135
- DOI: 10.1023/a:1007078114674
Haptoglobin glycoforms in a case of carbohydrate-deficient glycoprotein syndrome
Abstract
Alterations in haptoglobin (Hp) glycosylation were examined in the plasma of the first patient with carbohydrate-deficient glycoprotein syndrome (CDGS) who was described in Poland. Hp concentration in the CDGS patient plasma was low (240 mg/l) and the Hp phenotype was shown to be 2-2. Three glycoforms of the Hp beta subunit were observed in SDS-PAGE in CDGS. The densitometric analysis and molecular weight determinations suggested that 50% of glycoforms were fully glycosylated; 30% contained three out of four and 20% only two out of four glycan units compared to those that are present in Hp derived from healthy people. Results with lectins (concanavalin A and Sambucus nigra, Maackia amurensis and Alleuria aurantia agglutinins) indicate that all three glycoforms of beta subunit of CDGS-Hp contained biantennary complex glycans terminated with alpha2,6 bound sialic acid, but without fucose or alpha2,3 linked sialic acid. Hp glycosylation abnormalities described in this work suggest that this case was a type I carbohydrate-deficient glycoprotein syndrome.
Similar articles
-
The identification of abnormal glycoforms of serum transferrin in carbohydrate deficient glycoprotein syndrome type I by capillary zone electrophoresis.Glycoconj J. 1996 Dec;13(6):1031-42. doi: 10.1007/BF01053199. Glycoconj J. 1996. PMID: 8981095
-
Glycoforms of six serum glycoproteins in a patient with congenital disorder of glycosylation type I.Arch Immunol Ther Exp (Warsz). 2002;50(1):67-73. Arch Immunol Ther Exp (Warsz). 2002. PMID: 11916311
-
Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I.Clin Chem. 1999 Sep;45(9):1408-13. Clin Chem. 1999. PMID: 10471642
-
Carbohydrate-deficient glycoprotein syndromes: inborn errors of protein glycosylation.Ann Clin Biochem. 1999 Jan;36 ( Pt 1):20-36. doi: 10.1177/000456329903600103. Ann Clin Biochem. 1999. PMID: 10370757 Review.
-
Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: evidence for two different mechanisms.Glycoconj J. 1995 Jun;12(3):211-8. doi: 10.1007/BF00731322. Glycoconj J. 1995. PMID: 7496134 Review.
Cited by
-
Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients.PLoS One. 2012;7(12):e52040. doi: 10.1371/journal.pone.0052040. Epub 2012 Dec 18. PLoS One. 2012. PMID: 23272204 Free PMC article.
-
Glycosylation and over-expression of endometriosis-associated peritoneal haptoglobin.Glycoconj J. 2002 Jan;19(1):33-41. doi: 10.1023/a:1022580813870. Glycoconj J. 2002. PMID: 12652078
-
Changes in glycosylation of human blood plasma chitotriosidase in patients with type 2 diabetes.Glycoconj J. 2016 Feb;33(1):29-39. doi: 10.1007/s10719-015-9629-z. Glycoconj J. 2016. PMID: 26494371
-
A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.JCI Insight. 2024 Apr 8;9(7):e172509. doi: 10.1172/jci.insight.172509. JCI Insight. 2024. PMID: 38587076 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous